Today, J&J’s Ethicon announced that its robotic surgery platform, Monarch, officially received FDA 510(k) clearance. Ethicon’s Auris Health subsidy received the FDA clearance for Monarch for its endourological procedures. Officials of Ethicon say it is now the first and only multispecialty, flexible robotic solution for use in bronchoscopy and urology, respectively. Ethicon stated in a
On April 7th, 1948, the World Health Organization (WHO) was founded. As a result, April 7th is noted as a celebration to commemorate the organization’s founding and global contributions. Each year, a theme is chosen to signify the past and what the future focus of health should entail. For 2022, the chosen theme is “Our
Earlier this month Saluda Medical, a global medical device company developing in the field of neuromodulation, announced $125M in equity funding. Throughout the last decade, Saluda has evolved innovations designed to read, record, and respond to the nervous system during stimulation. The technology is able to provide dosing that can be titrated at the microsecond
2020 and 2021 were swarmed by the global COVID-19 pandemic and all of its additional variants. As we begin to see the light, and the faces (without masks), at the end of the tunnel, manny issues brought on by the global pandemic and other factors have continued into 2022. Despite how badly everyone wants the
Vital signs act as an integral piece of communication for a clinician to understand a patient’s condition & disease severity. As patient monitors continuously observe and provide notifications in the case of a serious event, it is important that any anomalous values are alerted to clinicians and provide physiological input data to control connected life
What Are Skin Substitutes? Skin substitutes are a group of biologic, synthetic, or biosynthetic materials designed to provide temporary or permanent coverage of skin wounds. The aim of skin substitutes is to replicate the properties of organic, cellular skin. They’re an important addition in the management of acute or chronic wounds and are often utilized
iData’s analysts work extensively to retrieve data and source both syndicated and custom market research reports. Owing to their in-depth understanding of the markets and first-hand experience with the appropriate data, our analysts have assessed Ambu’s ability to lead the single-use endoscope market into 2022. In 2009, Ambu A/S developed the first single-use endoscope and
Each year, it is estimated that over 57,000 women are diagnosed with invasive cervical cancer. Although preventable through vaccination and appropriate screening, one in four women and people with a cervix do not attend cervical screening. As leaders within the medical industry, we must continue to educate our communities and change this notion. During Cervical
As we see a severe global increase in the COVID-19 variant, Omicron, iData has noticed trends following this leg of the pandemic affecting the U.S. medical markets, more specifically, the U.S. urological device market. As market demands continue to undergo consolidation with hospitals acquiring outpatient facilities as well as reimbursement cuts across the overall urology
The effects of COVID-19 on the medical device market was substantial, and almost two years later, some markets are still dealing with the aftermath of a global pandemic. However, some companies rose to the occasion and chose to market their medical device alternatives to a population prepared to stay home. The FIT-DNA Test has done
